{
  "id": "Ex093",
  "type": "Example",
  "informationId": {
    "id": "CritAssess374",
    "type": "CriterionAssessment",
    "explanation": "Flag-tagged construct with the variant was transfected into HEK cells. As per the RASopathy working group’s approved assays (see example 3 above), Smith et al. showed that the Y337C mutation increased levels of pERK in starved HEK cells via western blotting.",
    "criterion": {
      "id": "PS3",
      "type": "Criterion",
      "description": "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product",
      "shortDescription": "Well-established functional studies showing damaging effect",
      "defaultStrength": {
        "id": "CG-evidence-strength:ps"
      }
    },
    "variant": {
      "id": "CanAll124",
      "type": "CanonicalAllele",
      "preferredCtxAllele": "CtxAll130",
      "identifier": "http://reg.genome.network/allele/CA090930"
    },
    "outcome": {
      "id": "CG-criterion-outcome:met",
      "type": "Coding",
      "code": "met",
      "system": "http://clinicalgenome.org/datamodel/criterion-assertion-outcome/",
      "display": "Met"
    },
    "evidence": [
      {
        "id": "EvLn116",
        "type": "EvidenceLine",
        "explanation": "EvLn116",
        "information": [
          {
            "id": "Func067",
            "type": "FunctionalData",
            "explanation": "PMID: 23487764",
            "result": "increased ERK activtation",
            "dataType": {
              "id": "CC055",
              "type": "CodeableConcept",
              "coding": [
                {
                  "id": "CG-func-data-type:activation",
                  "type": "Coding",
                  "code": "activation",
                  "system": "http://clinicalgenome.org/datamodel/functional-data-type/",
                  "display": "Activation Assay"
                }
              ]
            },
            "contextualAllele": {
              "id": "CtxAll130",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": {
                "id": "CanAll124",
                "type": "CanonicalAllele",
                "preferredCtxAllele": "CtxAll130",
                "identifier": "http://reg.genome.network/allele/CA090930"
              },
              "alleleName": "NM_005633.3(SOS1):c.1010A>G (p.Tyr337Cys)"
            },
            "gene": {
              "id": "hgnc:SOS1",
              "type": "Gene",
              "symbol": "SOS1"
            }
          }
        ]
      }
    ],
    "contribution": [
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent007",
          "type": "Agent",
          "name": "Stefan DiMarino"
        },
        "onDate": "3/14/2017 10:29 AM",
        "role": {
          "id": "CC415",
          "type": "CodeableConcept",
          "coding": [
            {
              "id": "CG-contributory-role:assessor",
              "type": "Coding",
              "code": "assessor",
              "system": "http://clinicalgenome.org/datamodel/contributory-role/",
              "display": "assessor"
            }
          ]
        }
      }
    ]
  },
  "index": 4,
  "author": "Marina DiStefano",
  "description": "Assessed Variant: NM_005633.3(SOS1):c.1010A>G (p.Tyr337Cys)\nPMID: 23487764\n\nA Flag-tagged construct with the variant was transfected into HEK cells. As per the RASopathy working group’s approved assays (see example 3 above), Smith et al. showed that the Y337C mutation increased levels of pERK in starved HEK cells via western blotting. Thus, PP4 can be applied."
}
